课题基金 / 基金详情

Identification and characterization of monogenic causes of hereditary kidney disease for the development of novel drug therapies.

Identification and characterization of monogenic causes of hereditary kidney disease for the development of novel drug therapies.
遗传性肾病单基因病因的鉴定和表征，用于开发新的药物疗法。
批准号：
363819
负责人：
Kitzler Thomas M
金额：
$5.46万
依托单位：
Boston Children's Hospital (Boston, MA)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-11-01 至 2019-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=363819&lang=en
关键词：
Drug Discovery Hereditary Kidney Disease Nephrology Nephronophthisis Nephronophthisis Related Ciliopathies Whole Exome Sequencing Zebrafish Animal Models

项目摘要

项目成果

Kitzler Thomas M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic kidney disease greatly affects the health of the general population. Nephronophthisis is the most frequently inherited cause of chronic kidney disease in children and young. The term nephronophthisis refers to the wasting away (from Greek, phthisi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A comprehensive approach to study genetic causes of chronic kidney disease
A comprehensiveapproach to studygenetic causes ofchronic kidney disease
  • 批准号：
    438804
  • 项目类别：
    Operating Grants
  • 资助金额：
    $0.0万
  • 财政年份：
    2020
  • 负责人：
    Kitzler Thomas M
  • 依托单位：
    McGill University
Identification and characterization of monogenic causes of hereditary kidney disease for the development of novel drug therapies.
海外基金